What are Bacteriocins?
Bacteriocins are a kind of ribosomal synthesized antimicrobial peptides produced by bacteria, which can kill or inhibit bacterial strains closely-related or non-related to produced bacteria, but will not harm the bacteria themselves by specific immunity proteins. Bacteriocins have been shown to inhibit the growth of various cancer cell lines. Bacteriocins anticancer properties are profound due to their ability to differentiate cancer cells from non-cancer cells. Cancer cell membrane surfaces are negatively charged, whereas non-cancer cells are neutral.
What are their clinical significance?
Bacteriocins are a group of antimicrobial peptides produced by bacteria, capable of controlling clinically relevant susceptible and drug-resistant bacteria. Bacteriocins have been studied to be able to modify and improve their physicochemical properties, pharmacological effects, and biosafety.
Why choose BactPC?
BactPC is reviewed by experts in the fields of bioinformatics. Our tool is committed to fostering scientific discovery, advancing research, and contributing to the development of alternative antimicrobial strategies. With BactPC, you have the power to explore the diverse world of bacteriocins with confidence and precision.
How to Get Started?
Using BactPC is as easy as 1-2-3! Simply submit your bacteriocin sequence, and BactPC will swiftly generate predictions and functional classifications. Get ready to unlock a wealth of information on bacteriocin activity and unleash the potential of your antimicrobial research.
